LIPO Projected Dividend Yield
Lipella Pharmaceuticals Inc ( NASDAQ : LIPO )Lipella Pharmaceuticals is a clinical-stage biotechnology company focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. Co.'s product candidate, LP-10, is its reformulation of tacrolimus specifically optimized for topical deposition to the internal surface of the urinary bladder lumen using a proprietary drug delivery platform that it has developed. In a second program, Co. is developing another product candidate, LP-310, which employs a formulation similar to LP-10 and is intended to treat oral lichen planus. 20 YEAR PERFORMANCE RESULTS |
LIPO Dividend History Detail LIPO Dividend News LIPO Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |